| 1269 |
Increase, COX-2 expression
Short Name
Increase, COX-2 expression
|
1 |
Molecular |
Feb 9, 2017 |
Mar 20, 2018 |
21: Aryl hydrocarbon receptor activation leading to early life stage mortality, via increased COX-2
|
| 1268 |
Decrease, Excitatory postsynaptic potential
Short Name
Decrease, Excitatory postsynaptic potential
|
1 |
Tissue |
Feb 9, 2017 |
May 24, 2018 |
None
|
| 1267 |
Decrease, Ecdysis motor program activity
Short Name
Decrease, Ecdysis motor program activity
|
1 |
Tissue |
Feb 9, 2017 |
Sep 29, 2025 |
3 AOPs
|
| 1266 |
Decrease, Circulating crustacean cardioactive peptide
Short Name
Decrease, Circulating CCAP
|
1 |
Tissue |
Feb 9, 2017 |
May 24, 2018 |
3 AOPs
|
| 1265 |
Decrease, Fushi tarazu factor-1 gene expression
Short Name
Decrease, Ftz-f1 expression
|
1 |
Molecular |
Feb 9, 2017 |
Sep 26, 2025 |
4: Ecdysone receptor agonism leading to mortality via suppression of Ftz-f1
|
| 1264 |
Increase, Nuclear receptor E75b gene expression
Short Name
Increase, E75b expression
|
1 |
Molecular |
Feb 9, 2017 |
May 24, 2018 |
4: Ecdysone receptor agonism leading to mortality via suppression of Ftz-f1
|
| 1263 |
Necrosis
Short Name
Necrosis
|
1 |
Tissue |
Feb 7, 2017 |
Feb 7, 2017 |
2 AOPs
|
| 1262 |
Apoptosis
Short Name
Apoptosis
|
1 |
Cellular |
Feb 7, 2017 |
May 31, 2025 |
20 AOPs
|
| 1260 |
Direct mitochondrial inhibition
Short Name
Direct mitochondrial inhibition
|
1 |
Molecular |
Feb 7, 2017 |
Sep 16, 2017 |
205: AOP from chemical insult to cell death
|
| 1259 |
narcosis
Short Name
narcosis
|
1 |
Cellular |
Feb 7, 2017 |
Sep 16, 2017 |
205: AOP from chemical insult to cell death
|
| 1258 |
Decompartmentalization
Short Name
Decompartmentalization
|
1 |
Cellular |
Feb 7, 2017 |
Sep 16, 2017 |
205: AOP from chemical insult to cell death
|
| 1257 |
Induced parturition
Short Name
Induced parturition
|
0 |
Individual |
Jan 13, 2017 |
Jan 13, 2017 |
2 AOPs
|
| 1256 |
increased mantel display
Short Name
increased mantel display
|
0 |
Organ |
Jan 13, 2017 |
Jan 13, 2017 |
2 AOPs
|
| 1255 |
induced spawning
Short Name
induced spawning
|
1 |
Individual |
Jan 13, 2017 |
Jan 13, 2017 |
195: 5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase
|
| 1254 |
Infant leukaemia
Short Name
IFL
|
0 |
Individual |
Dec 16, 2016 |
Aug 1, 2022 |
202: Inhibitor binding to topoisomerase II leading to infant leukaemia
|
| 1253 |
MLL chromosomal translocation
Short Name
MLL translocation
|
1 |
Cellular |
Dec 16, 2016 |
Aug 1, 2022 |
202: Inhibitor binding to topoisomerase II leading to infant leukaemia
|
| 1252 |
Binding to (interferes with) topoisomerase II enzyme
Short Name
Binding, topoisomerase II
|
1 |
Molecular |
Dec 16, 2016 |
Aug 1, 2022 |
202: Inhibitor binding to topoisomerase II leading to infant leukaemia
|
| 1251 |
Chronic, Mucus hypersecretion
Short Name
Chronic, Mucus hypersecretion
|
1 |
Tissue |
Nov 29, 2016 |
Aug 25, 2021 |
None
|
| 1250 |
Decrease, Lung function
Short Name
Decreased lung function
|
1 |
Individual |
Nov 29, 2016 |
Sep 8, 2021 |
7 AOPs
|
| 1248 |
EGFR , Activation
Short Name
EGFR , Activation
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1247 |
EGFR , PPAR-alpha activation
Short Name
EGFR , PPAR-alpha activation
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1246 |
Lung function, Decrease
Short Name
Lung function, Decrease
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1245 |
Mucus , Hypersecretion
Short Name
Mucus , Hypersecretion
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1244 |
Mucus hypersecretion,
Short Name
Mucus hypersecretion,
|
0 |
|
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1243 |
Altered, Ca2+-calmodulin activated signal transduction
Short Name
Altered, Ca2+-calmodulin activated signal transduction
|
3 |
Cellular |
Nov 29, 2016 |
Jun 7, 2018 |
4 AOPs
|